Quinupramine
Clinical data | |
---|---|
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Elimination half-life | 33 hours |
Identifiers | |
| |
ECHA InfoCard | 100.046.149 |
Chemical and physical data | |
Formula | C21H24N2 |
Molar mass | 304.437 g·mol−1 |
Quinupramine (brand names Kevopril, Kinupril, Adeprim, Quinuprine) is a tricyclic antidepressant (TCA) used in Europe for the treatment of depression.[1][2]
Pharmacologically, quinupramine acts
Clinically, quinupramine is reported to be stimulating similarly to imipramine, desipramine, and demexiptiline.[4] It can be inferred that its in vivo metabolites may have stronger effects on the reuptake of norepinephrine and/or serotonin than quinupramine itself.[citation needed]
References
- ISBN 3-88763-075-0.
- ISBN 978-3-527-31058-6.
- ^ PMID 6098759.
- ISBN 0-306-47406-9.